Latest Brain tumor Stories

But the absolute excess for all cancers combined is low The researchers say that in a group of 10,000 young people, they would expect 39 cancers to occur during the next 10 years, but if they all had one CT scan, up to six extra cancers would occur. CT (computed tomography) scans have great medical benefits, but their increasing use since the 1980s has raised some concerns about possible cancer risks, particularly following exposures in childhood. Most previous studies have estimated...

IASIS MEDICAL Sees Substantial Opportunity In Offering IsoRay's Entire Product Line RICHLAND, Wash., May 21, 2013 /PRNewswire/ -- IsoRay, Inc. (AMEX: ISR), (http://www.isoray.com/), announced today that it has entered into an exclusive international distribution agreement with IASIS Medical for the sale of IsoRay's complete product line in Greece. IsoRay is a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for brain cancer, lung...

VANCOUVER, Canada and MENLO PARK, Calif., May 20, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) announced today that Jeffrey Bacha, president and CEO, will present at the Second Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel. The Company's presentation is scheduled to begin at 11:30 a.m. EDT and will be available via a live webcast. To access the webcast, go to:...

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Micki Klein for the organization she created in honor of her daughter. New York, NY (PRWEB) May 17, 2013 On May 17, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy praises Micki Klein for creating the organization Riah’s Rainbow, in honor of her daughter Mariah who lost her battle with brain cancer. According to a Green Bay Press Gazette...

FOUNDER OF PEDIATRIC CANCER CHARITY AVAILABLE TO ADDRESS THE PREVALENCE OF THE LEADING CANCER KILLER AMONG CHILDREN OCEANPORT, N.J., May 17, 2013 /PRNewswire-USNewswire/ -- May is National Brain Tumor Awareness Month. In the U.S. alone, 700,000 people are living with a brain tumor diagnosis. Of this number, approximately 28,000 were children. The number of new cases of pediatric brain tumors for 2013 ?is estimated at approximately 4,671 (or 12.8 each day). Five-year survival rate...

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, will host the 8th annual “Sounding Off For A Cure” Benefit Concert featuring The Wailers. New York, NY (PRWEB) May 16, 2013 On May 16, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, will host its 8th Annual “Sounding Off For A Cure” benefit concert on Thursday, June 6, 2013 at The Hammerstein in New York City at 6:00 PM. The concert is...

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey Bacha: During the past quarter, we continued to advance our lead product candidate VAL-083 in an ongoing brain cancer clinical trial. Our current trial is a dose-escalating study designed to evaluate the safety and efficacy of VAL-083 as a potential treatment for...

To Begin I-124-CLR1404 (LIGHT) Phase 2 Imaging Trial in Brain Cancer in Early 2014 MADISON, Wis., May 16, 2013 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today provided an update on its product pipeline, including I-124-CLR1404 (LIGHT) positron emission tomography (PET) imaging agent for solid tumor indications, I-131-CLR1404 (HOT) cancer-targeted molecular...

Up To 30 European Sites To Join 46 Active Sites In The US BETHESDA, Md., May 16, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®)-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax(®)-L for brain cancer has been initiated at King's College Hospital in the UK. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO) This is one of the first...

A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy. Recently published in the journal Clinical Cancer Research, the study provides the first preclinical evidence demonstrating that an ATM kinase...